ConforMIS Inc. (NASDAQ:CFMS) traded down 3% on Thursday . The company traded as low as $7.82 and last traded at $7.87, with a volume of 258,872 shares. The stock had previously closed at $8.11.

A number of research analysts have recently commented on CFMS shares. Canaccord Genuity reissued a “buy” rating on shares of ConforMIS in a report on Saturday, May 14th. Oppenheimer Holdings Inc. started coverage on ConforMIS in a report on Saturday, May 14th. They set a “buy” rating on the stock. Zacks Investment Research raised ConforMIS from a “sell” rating to a “hold” rating in a report on Wednesday, July 13th. Deutsche Bank AG lowered their price objective on ConforMIS from $26.00 to $12.00 and set a “buy” rating on the stock in a report on Friday, May 13th. Finally, Wells Fargo & Co. lowered ConforMIS from an “outperform” rating to a “market perform” rating in a report on Friday, May 13th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $15.40.

The stock’s 50 day moving average price is $7.59 and its 200-day moving average price is $8.87. The firm’s market cap is $323.54 million.

ConforMIS (NASDAQ:CFMS) last posted its earnings results on Monday, August 8th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.01. The business earned $19.30 million during the quarter, compared to analyst estimates of $18.02 million. During the same period in the previous year, the firm posted ($2.51) earnings per share. The firm’s revenue was up .5% on a year-over-year basis. On average, equities research analysts forecast that ConforMIS Inc. will post ($1.40) earnings per share for the current fiscal year.

In other news, Director Kenneth P. Fallon III sold 4,000 shares of the business’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $8.44, for a total value of $33,760.00. Following the sale, the director now directly owns 92,222 shares in the company, valued at $778,353.68. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

A hedge fund recently raised its stake in ConforMIS stock. RS Investment Management Co. LLC boosted its position in shares of ConforMIS Inc. (NASDAQ:CFMS) by 3.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,432,470 shares of the company’s stock after buying an additional 43,490 shares during the period. RS Investment Management Co. LLC owned about 3.52% of ConforMIS worth $24,767,000 as of its most recent SEC filing.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.